American Pharmaceutical News In Review

View online

Forward to a friend | Facebook | Twitter

April 30, 2018

Newsletter Sponsor

Is your API ready for scale-up? What to demand from your CDMO

A CDMO that can optimize your API synthesis process early during technology transfer will reduce the risk of project delay or failure. That will also help your molecule run more efficiently in their plant. And time is money.

	Industry News

Allergan Announces Second Positive Phase 3 Clinical Trial for Ubrogepant

AmerisourceBergen Foundation Creates Opioid Resource Grant Program

European CHMP Adopts Positive Opinion for Biktarvy

FDA Grants Breakthrough Therapy Designation to MASP-2 Inhibitor OMS721

Amgen Receives Positive CHMP Opinion to Expand Use of Prolia

Sangamo Announces $8 Million CIRM Grant for ST-400

	Featured Articles

Process Control and Monitoring for Continuous Production of Biopharmaceuticals Process Control and Monitoring for Continuous Production of Biopharmaceuticals This article gives an overview of strategies and current technologies that can help to address ... read more »

Size Exclusion Chromatography of Protein Biopharmaceuticals: Past, Present and Future Size Exclusion Chromatography of Protein Biopharmaceuticals: Past, Present and Future Size exclusion chromatography (SEC) is a historical technique, routinely applied for the separation ... read more »

	Featured Video

Watch Video: JRS Pharma presents an Interview with Tony Carpanzano, Director of R&D
JRS Pharma presents an Interview with Tony Carpanzano, Director of R&D
Tony Carpanzano, Director of R&D at JRS Pharma discusses the company's new formulation guide. read more »

Watch Poster: Applying QbD in Process and Impurity Control Strategy Development
Applying QbD in Process and Impurity Control Strategy Development
Joe DiMartino delivers the poster 'Applying QbD in Process and Impurity Control Strategy Development'. read more »

	Featured Products

FT 2 Tablet Friability Tester
read more »

FTPA2000-260PH Multi-point FT-NIR Analyzer
read more »

	Featured Whitepaper

Clear Route to Success
Clear Route to Success
To meet the needs of this segment, specialist pharmaceutical glass manufacturer SGD Pharma is focusing its attention, and its investment, on strengthening its capabilities to supply this critical ... read more »

The Race to Phase III: A Cautionary Tale of Scalability
The Race to Phase III: A Cautionary Tale of Scalability
As drug products move from preclinical through Phase IV development stages, clinical material demand grows tremendously. Production scale-up is rarely straightforward. Scaling up drug product ... read more »

	Events

Using Raman Spectroscopy for Quality Control of Packaged Raw Materials
Online – 05/23/2018
Raman is the most practical technique for raw material identity (ID) verification but it often requires a sampling step, which limits its ease and ... event details »

BIO International Convention
Boston, MA – 06/04/2018
BIO International Convention is back in Boston, June 4-7, to celebrate history-making innovation. Join the global biotech community to discover the ... event details »

This information is being brought to you because you are a subscriber to
American Pharmaceutical Review. To ensure delivery to your inbox,
please add newsletters@americanpharmaceuticalreview.com to your address book.

Manage your Subscription | Unsubscribe | Contact American Pharmaceutical Review

American Pharmaceutical Review
395 Oyster Point Blvd, Suite 300
South San Francisco, CA 94080 USA